Cargando…

Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier

BACKGROUND: Astrocytes and cerebral endothelial cells are important components of the blood-brain barrier (BBB). Disruption to this barrier through inflammation is a major contributor to Alzheimer’s disease (AD) pathology. The amyloid beta (Aβ) protein is known to exist in several forms and is a key...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffin, Jarred M., Kho, Dan, Graham, E. Scott, Nicholson, Louise F. B., O’Carroll, Simon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911157/ https://www.ncbi.nlm.nih.gov/pubmed/27309956 http://dx.doi.org/10.1371/journal.pone.0157483

Ejemplares similares

Biosensor Technology Reveals the Disruption of the Endothelial Barrier Function and the Subsequent Death of Blood Brain Barrier Endothelial Cells to Sodium Azide and Its Gaseous Products
por: Kho, Dan T., et al.
Publicado: (2017)

The Importance of Multifrequency Impedance Sensing of Endothelial Barrier Formation Using ECIS Technology for the Generation of a Strong and Durable Paracellular Barrier
por: Robilliard, Laverne D., et al.
Publicado: (2018)

Regulation of human cerebro-microvascular endothelial baso-lateral adhesion and barrier function by S1P through dual involvement of S1P(1) and S1P(2) receptors
por: Wiltshire, Rachael, et al.
Publicado: (2016)

Luteolin Inhibits Fibrillary β-Amyloid(1–40)-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways
por: Zhang, Jun-Xia, et al.
Publicado: (2017)

Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells
por: O’Carroll, Simon J., et al.
Publicado: (2015)

In Vitro Wounding Models Using the Electric Cell-Substrate Impedance Sensing (ECIS)-Zθ Technology
por: Gu, Andrea Y., et al.
Publicado: (2018)

Structural Remodeling Mechanism of the Toxic Amyloid Fibrillary Mediated by Epigallocatechin-3-gallate
por: Zhang, Nan, et al.
Publicado: (2022)

Real-Time Measurement of Melanoma Cell-Mediated Human Brain Endothelial Barrier Disruption Using Electric Cell-Substrate Impedance Sensing Technology
por: Anchan, Akshata, et al.
Publicado: (2019)

Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury
por: Griffin, Jarred M., et al.
Publicado: (2019)

ECIS technology reveals that monocytes isolated by CD14(+ve) selection mediate greater loss of BBB integrity than untouched monocytes, which occurs to a greater extent with IL-1β activated endothelium in comparison to TNFα
por: Kho, Dan Ting, et al.
Publicado: (2017)

Blood–brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy
por: Kozberg, Mariel G, et al.
Publicado: (2022)

Neuroprotective effects of statins against amyloid β-induced neurotoxicity
por: Li, Hsin-Hua, et al.
Publicado: (2018)

Comparison of Leading Biosensor Technologies to Detect Changes in Human Endothelial Barrier Properties in Response to Pro-Inflammatory TNFα and IL1β in Real-Time †
por: Hucklesby, James J. W., et al.
Publicado: (2021)

Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier
por: Keaney, James, et al.
Publicado: (2015)

Fibrillary Glomerulonephritis: An Update
por: Rosenstock, Jordan L., et al.
Publicado: (2019)

Development of an ethogram/guide for identifying feline emotions: a new approach to feline interactions and welfare assessment in practice
por: Nicholson, Sandra Louise, et al.
Publicado: (2021)

Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
por: Verberk, Inge M. W., et al.
Publicado: (2020)

Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance
por: Zhao, Zhen, et al.
Publicado: (2015)

Syndapin-2 mediated transcytosis of amyloid-β across the blood–brain barrier
por: M. Leite, Diana, et al.
Publicado: (2022)

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
por: Jiang, Xiaotong, et al.
Publicado: (2023)

A Case of Fibrillary Glomerulonephritis
por: Venkataraj, Maamannan, et al.
Publicado: (2022)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5
por: Crystal Chan, Sin Hang, et al.
Publicado: (2022)

Glial and endothelial blood-retinal barrier responses to amyloid-β in the neural retina of the rat
por: Anderson, Peter JB, et al.
Publicado: (2008)

Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease
por: Wang, Dong, et al.
Publicado: (2021)

Blood Cerebrospinal Fluid Barrier Function Disturbance Can Be Followed by Amyloid-β Accumulation
por: Suzuki, Yuji, et al.
Publicado: (2022)

Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time
por: Kho, Dan, et al.
Publicado: (2015)

Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
por: Ganne, Akshatha, et al.
Publicado: (2022)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017)

A Case of Posttransplant Fibrillary Glomerulonephritis
por: Ammayappan, Shiva Kumar, et al.
Publicado: (2023)

TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
por: Versele, Romain, et al.
Publicado: (2022)

Nanoparticulate flurbiprofen reduces amyloid-β(42) generation in an in vitro blood–brain barrier model
por: Meister, Sabrina, et al.
Publicado: (2013)

RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions
por: Askarova, Sholpan, et al.
Publicado: (2013)

IL-6 stimulates a concentration-dependent increase in MCP-1 in immortalised human brain endothelial cells
por: Choi, Jai Min, et al.
Publicado: (2016)

Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: You, Huajing, et al.
Publicado: (2021)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Fibrillary Glomerulonephritis in a Patient with Sjogren’s Syndrome
por: Lodhi, Muhammad Uzair, et al.
Publicado: (2018)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4g14jhiqebinh016q9l9oi4qgj